uric acid has been researched along with Secondary Hyperparathyroidism in 9 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we report the use of whole genome sequencing (WGS) to establish a diagnosis in a family in which individuals were affected with gout, hyperuricemia associated with reduced fractional excretion of uric acid, chronic kidney disease (CKD), and secondary hyperparathyroidism, that are consistent with familial juvenile hyperuricemic nephropathy (FJHN)." | 3.96 | Whole genome sequence analysis identifies a PAX2 mutation to establish a correct diagnosis for a syndromic form of hyperuricemia. ( Gorvin, CM; Lhotta, K; Lines, KE; Pagnamenta, AT; Philpott, C; Reichart, S; Stevenson, M; Taylor, JC; Thakker, RV, 2020) |
| "Hyperuricemia is common among patients with chronic kidney disease (CKD)." | 1.72 | Hyperuricemia is associated with secondary hyperparathyroidism in patients with chronic kidney disease. ( Coelho, VA; Costa, TEM; Elias, RM; Innecchi, MLR; Lauar, JC; Moysés, RMA, 2022) |
| "Fourteen of 52 unselected patients with systemic lupus erythematosus (SLE) (27%) had ligamentous derangement demonstrated by either Jaccoud's syndrome and/or patellar tendon elongation." | 1.28 | Tendinous laxity and Jaccoud's syndrome in patients with systemic lupus erythematosus. Possible role of secondary hyperparathyroidism. ( Arturi, A; Babini, JC; Babini, SM; Cocco, JA; de la Sota, M; Marcos, JC; Morteo, OG, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Costa, TEM | 1 |
| Lauar, JC | 1 |
| Innecchi, MLR | 1 |
| Coelho, VA | 1 |
| Moysés, RMA | 1 |
| Elias, RM | 1 |
| Yu, D | 1 |
| Zou, L | 1 |
| Jin, Y | 1 |
| Wei, M | 1 |
| Wu, X | 1 |
| Zuo, L | 1 |
| Wu, M | 1 |
| Jiang, Y | 1 |
| Lin, KM | 1 |
| Lu, CL | 1 |
| Hung, KC | 1 |
| Wu, PC | 1 |
| Pan, CF | 1 |
| Wu, CJ | 1 |
| Syu, RS | 1 |
| Chen, JS | 1 |
| Hsiao, PJ | 1 |
| Lu, KC | 1 |
| Stevenson, M | 1 |
| Pagnamenta, AT | 1 |
| Reichart, S | 1 |
| Philpott, C | 1 |
| Lines, KE | 1 |
| Gorvin, CM | 1 |
| Lhotta, K | 1 |
| Taylor, JC | 1 |
| Thakker, RV | 1 |
| Sugimoto, R | 1 |
| Watanabe, H | 1 |
| Ikegami, K | 1 |
| Enoki, Y | 1 |
| Imafuku, T | 1 |
| Sakaguchi, Y | 1 |
| Murata, M | 1 |
| Nishida, K | 1 |
| Miyamura, S | 1 |
| Ishima, Y | 1 |
| Tanaka, M | 1 |
| Matsushita, K | 1 |
| Komaba, H | 1 |
| Fukagawa, M | 1 |
| Otagiri, M | 1 |
| Maruyama, T | 1 |
| Sahin, E | 1 |
| Goçmen, AY | 1 |
| Gümüşlü, S | 1 |
| Sahin, M | 1 |
| Koçak, H | 1 |
| Tuncer, M | 1 |
| Elkoushy, MA | 1 |
| Andonian, S | 1 |
| Müller, D | 1 |
| Eggert, P | 1 |
| Babini, SM | 1 |
| Cocco, JA | 1 |
| de la Sota, M | 1 |
| Babini, JC | 1 |
| Arturi, A | 1 |
| Marcos, JC | 1 |
| Morteo, OG | 1 |
1 review available for uric acid and Secondary Hyperparathyroidism
| Article | Year |
|---|---|
The Paradoxical Role of Uric Acid in Osteoporosis.
Topics: Animals; Biomarkers; Bone and Bones; Bone Remodeling; Humans; Hyperparathyroidism, Secondary; Hyperu | 2019 |
1 trial available for uric acid and Secondary Hyperparathyroidism
| Article | Year |
|---|---|
Prolonged dietary calcium restriction: a diagnostic approach in idiopathic hypercalciuria.
Topics: Calcitriol; Calcium; Calcium, Dietary; Child; Child, Preschool; Diagnosis, Differential; Diet; Femal | 2001 |
7 other studies available for uric acid and Secondary Hyperparathyroidism
| Article | Year |
|---|---|
Hyperuricemia is associated with secondary hyperparathyroidism in patients with chronic kidney disease.
Topics: Adult; Aged; Aged, 80 and over; Allopurinol; Calcium; Cholecalciferol; Female; Furosemide; Humans; H | 2022 |
Semiquantitative assessment of
Topics: Alkaline Phosphatase; Calcitriol; Calcium; Creatinine; Cysteine Proteinase Inhibitors; Humans; Hyper | 2022 |
Whole genome sequence analysis identifies a PAX2 mutation to establish a correct diagnosis for a syndromic form of hyperuricemia.
Topics: Adult; Creatinine; DNA Mutational Analysis; Female; Heterozygote; Humans; Hyperparathyroidism, Secon | 2020 |
Down-regulation of ABCG2, a urate exporter, by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; Caco-2 Cells; Calcimimetic Agents; | 2017 |
Lipid peroxidation and parathyroid hormone influence the cytosolic calcium levels of erythrocytes in peritoneal dialysis patients.
Topics: Adult; Blood Cell Count; C-Reactive Protein; Calcium; Case-Control Studies; Cytosol; Erythrocytes; F | 2011 |
Characterization of patients with heterozygous cystinuria.
Topics: Adolescent; Adult; Age Factors; Aged; Calcium Oxalate; Child; Cystine; Cystinuria; Episode of Care; | 2012 |
Tendinous laxity and Jaccoud's syndrome in patients with systemic lupus erythematosus. Possible role of secondary hyperparathyroidism.
Topics: Adolescent; Adult; Arthritis; Calcium; Child; Creatinine; Female; Foot Deformities, Congenital; Hand | 1989 |